0
Correspondence |

Attention to Doping Controls Required When Prescribing for Athletes FREE TO VIEW

Andrew McD. Johnston, MRCPI
Author and Funding Information

University of Birmingham Birmingham, UK

Correspondence to: Andrew McD. Johnston, MRCPI, Specialist Registrar in Respiratory and Intensive Care Medicine, Department of Medicine, University of Birmingham, Birmingham B152TH, UK; e-mail: amcdj@doctors.org.uk



Chest. 2006;130(4):1283-1284. doi:10.1378/chest.130.4.1283-a
Text Size: A A A
Published online

To the Editor:

In their review of exercise-induced bronchoconstriction in athletes, Parsons and Mastronarde1advocate the use of β2-agonists and inhaled corticosteroids. Physicians who treat competitive athletes should be aware, however, that athletes competing at national and international levels require a “Therapeutic Use Exemption” for these classes of drug. This is a certificate obtainable from the athlete’s national sports federation or national antidoping agency, which allows their physician to inform the governing body that the athlete requires this treatment. The athlete may then be granted approval to use the drug, and avoid censure if it is unexpectedly found during antidoping tests.2

The authors have reported to the ACCP that no significant conflicts of interest exist with any companies/organizations whose products or services may be discussed in this article.

Parsons, JP, Mastronarde, JG (2005) Exercise-induced bronchoconstriction in athletes.Chest128,3966-3974
 
World Anti-Doping Agency. International standard for therapeutic use exemptions. Available at: www.wada-ama.org/en/dynamic.ch2? pageCategory.id=373. Accessed December 15, 2005.
 

Figures

Tables

References

Parsons, JP, Mastronarde, JG (2005) Exercise-induced bronchoconstriction in athletes.Chest128,3966-3974
 
World Anti-Doping Agency. International standard for therapeutic use exemptions. Available at: www.wada-ama.org/en/dynamic.ch2? pageCategory.id=373. Accessed December 15, 2005.
 
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543